| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Kezar Life Sciences, Inc. (KZR) has 10 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. KZR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 7.0K | $51.5K | - | |
| ? | 5.0K | $36.8K | - | |
| ? | 5.0K | $36.8K | - | |
| ? | 5.0K | $36.8K | - | |
| ? | 5.0K | $36.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 4, 2020 | Economides Vassiliki | SVP, Strategy &External Aff. | Buy | 5,769 | $2.60 | $14,999.40 | +320.3% | |
| Feb 4, 2020 | Kirk Christopher J. | President And CSO | Buy | 38,461 | $2.60 | $99,998.60 | +12.6% | |
| Feb 4, 2020 | Morningside Venture Investments Ltd93 | 10% Owner | Buy | 3,800,000 | $2.60 | $9,880,000.00 | +164.6% | |
| Nov 13, 2019 | Belsky Marc | CFO | Buy | 800 | $2.76 | $2,207.04 | +66.7% | |
| Oct 10, 2019 | Fowler John Franklin | CEO | Buy | 1,000 | $3.24 | $3,235.40 | +0.3% | |
| Aug 20, 2019 | Belsky Marc | CFO | Buy | 200 | $4.42 | $884.00 | +20.0% | |
| Aug 20, 2019 | Economides Vassiliki | SVP, Strategy &External Aff. | Buy | 350 | $4.41 | $1,543.57 | +24.1% | |
| Aug 13, 2019 | Kirk Christopher J. | President And CSO | Buy | 5,000 | $4.61 | $23,040.00 | +1.7% | |
| Aug 13, 2019 | Fowler John Franklin | CEO | Buy | 2,000 | $4.66 | $9,310.00 | +0.7% | |
| Aug 9, 2019 | Kirk Christopher J. | President And CSO | Buy | 5,000 | $4.97 | $24,830.00 | +1.7% |